Lack of birth defects following in utero paroxetine exposure

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2006年 / 1108卷 / 1期

关键词：

Pregnant Woman; Congenital Abnormality; Paroxetine; Pregnancy Outcome; Medium Release;

D O I：

10.2165/00128415-200611080-00005

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：3 / 3

相关论文

共 50 条

[1] Fluoxetine, paroxetine: birth defects after in utero exposure
Reactions Weekly, 2015, 1561 (1) : 6 - 6
[2] Lamivudine: lack of birth defects following paternal exposure
Reactions Weekly, 2002, 906 (1) : 3 - 3
[3] Neonatal complications following in utero paroxetine exposure
Reactions Weekly, 2003, 935-936 (1) : 4 - 4
[4] Fluoxetine/paroxetine/venlafaxineCongenital heart defects following in utero exposure: 7 case reports
Reactions Weekly, 2018, 1714 (1) : 193 - 193
[5] Birth defects following carbimazole in utero exposure : six more cases
Koenig, D.
Spreux, A.
Brucker-Davis, F.
Hieronimus, S.
Chichmanian, R. M.
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2009, 23 : 30 - 30
[6] In utero exposure to mebendazole not linked to major birth defects
Reactions Weekly, 1999, 746 (1) : 4 - 4
[7] In utero exposure to antivirals not found to increase birth defects
Reactions Weekly, 2010, 1317 (1) : 1 - 1
[8] Neonatal withdrawal syndrome following in utero exposure to paroxetine, clonazepam and olanzapine
K L Murray
K M Miller
D L Pearson
Journal of Perinatology, 2007, 27 : 517 - 518
[9] Darunavir/raltegravir/ritonavirVarious birth defects following in-utero exposure: 11 case reports
Reactions Weekly, 2021, 1857 (1) : 127 - 127
[10] PropylthiouracilFace, neck and urinary system birth defects following in utero exposure: 14 case reports
Reactions Weekly, 2015, 1561 (1) : 152 - 152

← 1 2 3 4 5 →